Health Secretary Robert F. Kennedy Jr. has once again drawn widespread attention after making controversial remarks during a recent Cabinet discussion with former President Donald Trump and other senior officials.
The meeting, which was expected to focus on public health priorities, instead reignited debate over Kennedy’s long-standing claims regarding a possible connection between the painkiller acetaminophen—commonly known as Tylenol—and autism spectrum disorder.
Although he acknowledged that no conclusive scientific evidence currently supports this theory, he reiterated his belief that further investigation…
CONTINUE READING…
CONTINUE READING…
Categories: News